Alisertib for Acute Myeloid Leukemia

Clinical trial NCT01779843 · COMPLETED

Trial details

NCT number: NCT01779843
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2013-04-01
Primary completion: 2015-11-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.